New innovative technology platform has creating the next generation of DNA or RNA vaccines based on the genetic code of the pathogenic agents. Drug delivery systems are come up with technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to upgrade health condition and increase lives. Technological advances in immunology, protein design, and genetic delivery have unlocked new possibilities for vaccine concepts and delivery technology that were previously inaccessible. The most important requirements are a vaccine should be safe and efficacious can be restated as a formulation that it is made with the appropriate potency that persists over the duration of conditions until it is administered to the patient.
Important Alert:
X
Title : Optimizing vaccine trial design: A novel promising zone approach with adaptive Interim analysis for managing delayed effects
Depeng Jiang, University of Manitoba, Canada
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : Distinct patterns of SARS-CoV-2 genetic variations
Jun Wan, Indiana University School of Medicine, United States
Title : The power of cultural validation when empowering community immunity
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States
Title : High dilution of Covid-19 positive throat swab shows prophylactic effect and its spectroscopic Studies
Anirban Sukul, Sukul Institute of Homeopathic Research, India
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Evaluating community-based vaccine initiatives with power BI
Carly Contri, American Academy of Pediatrics, United States
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Perception of HPV Vaccination among healthcare professionals in Morocco: Barriers and strategies for improving public acceptance
Filali Houda, Hassan 2 university, Morocco
Title : High prevalence of zero-dose children in underserved and special setting populations in ethiopia using a generalize estimating equation and concentration index analysis
Gashaw Andargie Biks, Project HOPE, Ethiopia